Tumour immunology: false hopes - new horizons?

被引：29
作者：
Alexandroff, AB
Robins, RA
Murray, A
James, K
机构：
[1] Univ Edinburgh, Royal Infirm, Dept Surg, Edinburgh EH3 9YW, Midlothian, Scotland
[2] Queens Med Ctr, Dept Immunol, Nottingham NG7 2UH, England
[3] Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield, S Yorkshire, England
来源：
IMMUNOLOGY TODAY | 1998年 / 19卷 / 06期
关键词：
D O I：
10.1016/S0167-5699(98)01265-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
For the past 100 years, tumour immunology has witnessed peaks and troughs of interest. A recent meeting* covered new technologies and recent developments in the field.
引用
收藏
页码：247 / 250
页数：4
相关论文
共 16 条
[1]  
ALEXANDROFF AB, IN PRESS BR J CANC
[2]   Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappa B pathway involving TNF receptor-associated factors [J].
Eliopoulos, AG ;
Stack, M ;
Dawson, CW ;
Kaye, KM ;
Hodgkin, L ;
Sihota, S ;
Rowe, M ;
Young, LS .
ONCOGENE, 1997, 14 (24) :2899-2916
[3]  
Evans EML, 1997, CANCER RES, V57, P2943
[4]   Response of B-cell lymphoma to a combination of bispecific antibodies and saporin [J].
French, RR ;
Bell, AJ ;
Hamblin, TJ ;
Tutt, AL ;
Glennie, MJ .
LEUKEMIA RESEARCH, 1996, 20 (07) :607-617
[5]  
GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637
[6]   A central role of CD40 ligand in the regulation of CD4(+) T-cell responses [J].
Grewal, IS ;
Flavell, RA .
IMMUNOLOGY TODAY, 1996, 17 (09) :410-414
[7]   EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS [J].
GUO, YJ ;
WU, MC ;
CHEN, H ;
WANG, XN ;
LIU, GL ;
LI, GL ;
MA, J ;
SY, MS .
SCIENCE, 1994, 263 (5146) :518-520
[8]  
KIENER PA, 1995, J IMMUNOL, V155, P4917
[9]  
KOHO H, 1984, CANCER IMMUNOL IMMUN, V17, P165
[10]  
Mackey MF, 1997, CANCER RES, V57, P2569
12